NASDAQ:TCBP

TC Biopharm (TCBP) Stock Price, News & Analysis

$1.13
-0.01 (-0.88%)
(As of 05/17/2024 ET)
Today's Range
$1.11
$1.15
50-Day Range
$1.12
$1.95
52-Week Range
$0.85
$20.00
Volume
251,402 shs
Average Volume
2.59 million shs
Market Capitalization
$3.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TCBP stock logo

About TC Biopharm Stock (NASDAQ:TCBP)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TCBP Stock Price History

TCBP Stock News Headlines

Why Is TC Biopharm (TCBP) Stock Up 51% Today?
Why Is TC Biopharm (TCBP) Stock Up 78% Today?
TCBP Adjourns General Meeting Until a Later Date
TCBP Announces Exercise of Series D Warrants For Cash
/C O R R E C T I O N -- TC BioPharm/
See More Headlines
Receive TCBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TCBP
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
$3.25 per share

Miscellaneous

Free Float
3,193,000
Market Cap
$3.62 million
Optionable
Not Optionable
Beta
0.13
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Bryan L. Kobel (Age 45)
    CEO & Director
  • Mr. Martin E. Thorp (Age 72)
    CFO & Director
  • Mr. Christopher Camarra
    Executive Vice President of Communications
  • Dr. Lauren Bor Ph.D.
    Head of Commercial Development Division

TCBP Stock Analysis - Frequently Asked Questions

How have TCBP shares performed in 2024?

TC Biopharm's stock was trading at $3.17 at the start of the year. Since then, TCBP shares have decreased by 64.4% and is now trading at $1.13.
View the best growth stocks for 2024 here
.

When did TC Biopharm's stock split?

Shares of TC Biopharm reverse split on Friday, December 15th 2023. The 1-20 reverse split was announced on Friday, December 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did TC Biopharm IPO?

TC Biopharm (TCBP) raised $17 million in an IPO on Friday, February 11th 2022. The company issued 4,100,000 shares at $4.25 per share. EF Hutton served as the underwriter for the IPO.

How do I buy shares of TC Biopharm?

Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TCBP) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners